Millennium Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-31,700
Closed -$68.2K 4636
2024
Q3
$68.2K Sell
31,700
-31,314
-50% -$67.3K ﹤0.01% 3901
2024
Q2
$325K Sell
63,014
-198,069
-76% -$1.02M ﹤0.01% 3377
2024
Q1
$1.4M Buy
+261,083
New +$1.4M ﹤0.01% 2782
2023
Q3
Sell
-12,825
Closed -$40.4K 4709
2023
Q2
$40.4K Sell
12,825
-65,511
-84% -$206K ﹤0.01% 3988
2023
Q1
$209K Sell
78,336
-13,137
-14% -$35K ﹤0.01% 3841
2022
Q4
$328K Buy
91,473
+21,839
+31% +$78.3K ﹤0.01% 3853
2022
Q3
$448K Sell
69,634
-26,776
-28% -$172K ﹤0.01% 3924
2022
Q2
$928K Buy
96,410
+45,228
+88% +$435K ﹤0.01% 3474
2022
Q1
$609K Buy
51,182
+41,952
+455% +$499K ﹤0.01% 3942
2021
Q4
$301K Sell
9,230
-22,408
-71% -$731K ﹤0.01% 4399
2021
Q3
$1.41M Sell
31,638
-24,133
-43% -$1.08M ﹤0.01% 3341
2021
Q2
$3.04M Buy
55,771
+38,892
+230% +$2.12M ﹤0.01% 2693
2021
Q1
$1.26M Sell
16,879
-21,148
-56% -$1.58M ﹤0.01% 3112
2020
Q4
$4.13M Buy
38,027
+22,924
+152% +$2.49M ﹤0.01% 2045
2020
Q3
$1.34K Sell
15,103
-203
-1% -$18 ﹤0.01% 2301
2020
Q2
$1.63M Buy
+15,306
New +$1.63M ﹤0.01% 2132
2020
Q1
Sell
-52,559
Closed -$3.63M 3755
2019
Q4
$3.63M Buy
52,559
+50,681
+2,699% +$3.5M ﹤0.01% 1755
2019
Q3
$194K Buy
+1,878
New +$194K ﹤0.01% 3156
2019
Q2
Sell
-6,972
Closed -$637K 3852
2019
Q1
$637K Sell
6,972
-2,647
-28% -$242K ﹤0.01% 2648
2018
Q4
$536K Sell
9,619
-7,666
-44% -$427K ﹤0.01% 2573
2018
Q3
$2.06M Sell
17,285
-20,262
-54% -$2.41M ﹤0.01% 2126
2018
Q2
$3.83M Buy
37,547
+21,170
+129% +$2.16M 0.01% 1757
2018
Q1
$2.13M Buy
+16,377
New +$2.13M ﹤0.01% 2112
2017
Q4
Sell
-11,321
Closed -$1.67M 3794
2017
Q3
$1.67M Buy
+11,321
New +$1.67M ﹤0.01% 2074
2017
Q2
Sell
-1,165
Closed -$186K 3620
2017
Q1
$186K Buy
+1,165
New +$186K ﹤0.01% 2996